GlaxoSmithKline (CAI:BIOC) OCF Margin %: 26.62% (As of Sep. 2016)


What is GlaxoSmithKline OCF Margin %?

GlaxoSmithKline CAI:BIOC +1.17% OCF Margin % is 26.62% as of Sep. 2016.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. GlaxoSmithKline's Cash Flow from Operations for the three months ended in Sep. 2016 was E£71 Mil. GlaxoSmithKline's Revenue for the three months ended in Sep. 2016 was E£268 Mil. Therefore, GlaxoSmithKline's OCF Margin % for the quarter that ended in Sep. 2016 was 26.62%.

As of today, GlaxoSmithKline's current OCF Yield % is 0.00%.

The historical rank and industry rank for GlaxoSmithKline's OCF Margin % or its related term are showing as below:

CAI:BIOC' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 6.64

CAI:BIOC's OCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 9.95 vs CAI:BIOC: 6.64

GlaxoSmithKline OCF Margin % Related Terms

GlaxoSmithKline OCF Margin % Historical Data

* Premium members only.

The historical data trend for GlaxoSmithKline's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline OCF Margin % Chart

GlaxoSmithKline Annual Data
Trend Dec12 Dec13 Dec14 Dec15
OCF Margin %
15.99 26.00 19.12 16.54

GlaxoSmithKline Quarterly Data
Dec12 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.77 44.21 -39.32 -5.84 26.62

CAI:BIOC vs PRPH: OCF Margin % Comparison

For the Drug Manufacturers - General subindustry, GlaxoSmithKline's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline's OCF Margin % distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline's OCF Margin % falls into.


GlaxoSmithKline OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

GlaxoSmithKline's OCF Margin for the fiscal year that ended in Dec. 2015 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2015 )/Revenue (A: Dec. 2015 )
=168.896/1020.948
=16.54 %

GlaxoSmithKline's OCF Margin for the quarter that ended in Sep. 2016 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2016 )/Revenue (Q: Sep. 2016 )
=71.276/267.715
=26.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 26.62% mean?
GlaxoSmithKline (CAI:BIOC) has a OCF Margin % of 26.62% as of Sep. 2016. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GlaxoSmithKline and its competitors.
Is GlaxoSmithKline's OCF Margin % too high?
GlaxoSmithKline's current OCF Margin % is 26.62%. The Drug Manufacturers industry median OCF Margin % is 9.95. GlaxoSmithKline's value of 26.62% is 167.5% above this industry median.
How does GlaxoSmithKline's OCF Margin % compare to PRPH?
GlaxoSmithKline's OCF Margin % of 26.62% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 9.95. GlaxoSmithKline's value of 26.62% is 167.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GlaxoSmithKline's current OCF Margin % of 26.62% is 167.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on GlaxoSmithKline and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GlaxoSmithKline's current OCF Margin % is 26.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline stock overvalued right now?
GlaxoSmithKline (CAI:BIOC) has a current OCF Margin % of 26.62%. The current OCF Margin % is 26.62% and 167.5% above the Drug Manufacturers industry median of 9.95. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For GlaxoSmithKline (CAI:BIOC), the current OCF Margin % is 26.62% as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlaxoSmithKline Business Description

Address Boomerang Building, No 46, Block (J) First Section City Centre, Town Centre, Second floor, Fifth District - New Cairo, Cairo, EGY, 11835
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.